Northwest & Ethical Investments L.P. Pacira Bio Sciences, Inc. Transaction History

Northwest & Ethical Investments L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jul 09, 2025	SELL	$26.32 - $34.31 $1.85 Million - $2.41 Million	-70,325 Closed	0 $0
Q2 2023 Jul 09, 2025	SELL	$36.12 - $47.5 $1.25 Million - $1.64 Million	-34,606 Reduced 32.98%	70,325 $2.82 Billion
Q1 2023 Jul 09, 2025	SELL	$35.53 - $43.38 $58,837 - $71,837	-1,656 Reduced 1.55%	104,931 $4.28 Billion
Q4 2022 Jul 09, 2025	BUY	$38.19 - $57.45 $427,460 - $643,037	11,193 Added 11.73%	106,587 $4.12 Billion
Q2 2022 Jul 09, 2025	BUY	$51.49 - $81.64 $262,187 - $415,710	5,092 Added 5.64%	95,394 $5.56 Billion

Q1 2022 Jul 09, 2025	BUY	$60.03 - $76.49 $5.42 Million - $6.91 Million	90,302 New	90,302 $6.89 Billion
Q4 2021 Jul 09, 2025	BUY	$47.97 - $62.21 $1.71 Million - $2.21 Million	35,582 New	35,582 $2.14 Billion

261

48.9M

118K

63.7K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.09B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Northwest & Ethical Investments L.P., based on Form 13F filings with the SEC.

Stay updated on Northwest & Ethical Investments L.P. with notifications on news.